Cadila Healthcare's Q2 net up 33% to Rs 503 cr

Cadila Healthcare Limited, also known as Zydus Cadila, reported a net profit growth of 33 per cent at Rs 503 crore in second quarter ended September 30, 2017, up from roughly Rs 378 crore for the said period last year.

While total income from operations grew by 35 per cent year-on-year in Q2 to stand at Rs 3,234 crore, Cadila Healthcare's business in the US posted sales of Rs 1,644 crore, up by 66 per cent, the company stated in an official communique.

During the quarter, the company launched four new products in the US including Mesalamine Delayed Release 1.2